Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:30 ET
|
Mersana Therapeutics, Inc.
CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to June 3, 2024
May 03, 2024 16:30 ET
|
Vision Sensing Acquisition Corp.
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to June 3, 2024
Territorial Bancorp Inc. Announces First Quarter 2024 Results
May 03, 2024 16:30 ET
|
Territorial Bancorp Inc.
The Company’s tier one leverage and risk-based capital ratios were 11.58% and 28.84%, respectively, and the Company is considered to be “well-capitalized” at March 31, 2024.Ratio of non-performing...
Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units
May 03, 2024 16:30 ET
|
Brookfield Property Partners L.P.
All dollar references are in U.S. dollars, unless noted otherwise. BROOKFIELD NEWS, May 03, 2024 (GLOBE NEWSWIRE) -- Brookfield Property Partners (“BPY” or the "Partnership") announced today that...
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
May 03, 2024 16:30 ET
|
Fate Therapeutics, Inc.
Off-the-shelf, CD19-targeted CAR NK Cell Product Candidate Drives Rapid and Deep Depletion of SLE Donor CD19+ B cells ADR Technology Incorporated into FT522 Induces Functional Persistence and...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:30 ET
|
ORIC Pharmaceuticals
SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Jayud Global Logistics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5550(b)(1)
May 03, 2024 16:30 ET
|
Jayud Global Logistics Ltd
SHENZHEN, China, May 03, 2024 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen,...
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:30 ET
|
Dianthus Therapeutics, Inc.
NEW YORK and WALTHAM, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (“Dianthus”), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody...
Enstar Group Limited Announces Quarterly Preference Share Dividends
May 03, 2024 16:15 ET
|
Enstar Group Limited
HAMILTON, Bermuda, May 03, 2024 (GLOBE NEWSWIRE) -- Enstar Group Limited (“Enstar”) (Nasdaq: ESGR) today announced that it will pay cash dividends on its Series D and Series E preference shares. ...